z-logo
Premium
Interleukin‐10 gene polymorphism reflects the severity of chronic immune thrombocytopenia in Japanese patients
Author(s) -
SAITOH T.,
KASAMATSU T.,
INOUE M.,
MITSUI T.,
KOISO H.,
YOKOHAMA A.,
HANDA H.,
MATSUSHIMA T.,
TSUKAMOTO N.,
KARASAWA M.,
OGAWARA H.,
NOJIMA Y.,
MURAKAMI H.
Publication year - 2011
Publication title -
international journal of laboratory hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.705
H-Index - 55
eISSN - 1751-553X
pISSN - 1751-5521
DOI - 10.1111/j.1751-553x.2011.01320.x
Subject(s) - haplotype , genotype , immune system , immunology , platelet , medicine , polymorphism (computer science) , single nucleotide polymorphism , gene polymorphism , gastroenterology , gene , biology , genetics
Summary Introduction:  T‐helper cell type 1 (Th1) polarization of the immune response has been documented in patients with chronic immune thrombocytopenia (ITP). Interleukin (IL)‐10 is the most important factor regulating Th1 and T‐helper type 2 cytokine synthesis. This study evaluated the impact of IL‐10 polymorphisms on both susceptibility to, and severity of, chronic ITP. Methods:  We analyzed ‐1082(G/A), ‐812(C/T), and ‐592(C/A) IL‐10 polymorphisms in 90 patients with adult chronic ITP and 202 race‐ and sex‐matched healthy controls. Results:  No significant differences in the genotype or haplotype frequencies were observed between the patient with chronic ITP and the control group. However, more patients with the ‐592AA genotype showed a severe thrombocytopenic state (platelet count <10 × 10 9 /l) than those with the ‐592CC/CA genotypes (44.1% vs. 19.6%, P  = 0.01). Furthermore, more patients with the ATA/ATA haplotype showed a severe thrombocytopenic state than those without the ATA/ATA haplotype (44.1% vs. 19.6%, P  = 0.01). Conclusion:  According to our data, patients with low producer type of IL‐10 polymorphisms have more severe thrombocytopenia, suggesting that IL‐10 gene polymorphisms may reflect the severity of ITP.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here